This inventor holds 4 USPTO granted patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2008-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokushima, JP (2010)
- Tokushima-ken, JP (2008 - 2013)
Company Filing History:
Years Active: 2008-2013
Title: Yuichiro Fukunaga: Innovator in Dry Powder Inhalation Systems
Introduction
Yuichiro Fukunaga is a notable inventor based in Tokushima-ken, Japan. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of dry powder inhalation systems. With a total of 4 patents to his name, Fukunaga's work is recognized for its innovative approach to drug delivery.
Latest Patents
Fukunaga's latest patents include a dry powder inhalation system designed for transpulmonary administration. This system is characterized by its unique combination of features that enhance the effectiveness of drug delivery. The invention aims to provide a novel solution for patients requiring pulmonary medication, ensuring that the inhalation process is both efficient and user-friendly.
Career Highlights
Yuichiro Fukunaga is currently employed at Otsuka Pharmaceutical Company, Limited, where he continues to advance his research and development efforts. His work at Otsuka has allowed him to focus on innovative solutions that address the needs of patients and healthcare providers alike.
Collaborations
Fukunaga has collaborated with esteemed colleagues such as Chikamasa Yamashita and Akitsuna Akagi. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their innovations.
Conclusion
In summary, Yuichiro Fukunaga is a distinguished inventor whose work in dry powder inhalation systems has the potential to transform pulmonary drug delivery. His contributions to Otsuka Pharmaceutical Company and collaborations with fellow innovators underscore his commitment to advancing healthcare technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
